A new trading day began on Tuesday, with Co-Diagnostics Inc (NASDAQ: CODX) stock price up 7.36% from the previous day of trading, before settling in for the closing price of $0.26. CODX’s price has ranged from $0.23 to $2.23 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales drop of Healthcare Sector giant was -27.40%. Meanwhile, its annual earnings per share averaged 13.71%. With a float of $30.68 million, this company’s outstanding shares have now reached $33.57 million.
Let’s determine the extent of company efficiency that accounts for 132 employees. In terms of profitability, gross margin is -12.25%, operating margin of -4079.44%, and the pretax margin is -3574.77%.
Co-Diagnostics Inc (CODX) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Medical Devices Industry. The insider ownership of Co-Diagnostics Inc is 9.00%, while institutional ownership is 17.44%.
Co-Diagnostics Inc (CODX) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.16 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 13.71% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 37.69% during the next five years compared to -27.40% drop over the previous five years of trading.
Co-Diagnostics Inc (NASDAQ: CODX) Trading Performance Indicators
Here are Co-Diagnostics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 4.23. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 16.57.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.14, a number that is poised to hit -0.62 in the next quarter and is forecasted to reach -0.42 in one year’s time.
Technical Analysis of Co-Diagnostics Inc (CODX)
Looking closely at Co-Diagnostics Inc (NASDAQ: CODX), its last 5-days average volume was 0.29 million, which is a drop from its year-to-date volume of 0.31 million. As of the previous 9 days, the stock’s Stochastic %D was 40.22%.
During the past 100 days, Co-Diagnostics Inc’s (CODX) raw stochastic average was set at 10.50%, which indicates a significant decrease from 60.40% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0253 in the past 14 days, which was lower than the 0.0469 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.2978, while its 200-day Moving Average is $0.6869. However, in the short run, Co-Diagnostics Inc’s stock first resistance to watch stands at $0.2938. Second resistance stands at $0.3074. The third major resistance level sits at $0.3218. If the price goes on to break the first support level at $0.2658, it is likely to go to the next support level at $0.2514. Now, if the price goes above the second support level, the third support stands at $0.2378.
Co-Diagnostics Inc (NASDAQ: CODX) Key Stats
With a market capitalization of 9.45 million, the company has a total of 33,573K Shares Outstanding. Currently, annual sales are 3,920 K while annual income is -37,640 K. The company’s previous quarter sales were 50 K while its latest quarter income was -7,530 K.
